In a year where ADC deals have showed no signs of slowing, Solve has become the latest biotech to unlock an extra slice of capital.

Merus and Halozyme have signed a worldwide non-exclusive partnership and licence agreement for subcutaneous formulation of ...

Johnson & Johnson has signed a definitive agreement for the acquisition of Halda Therapeutics (Halda) in a deal valued at ...